Labcorp Holdings annual total assets
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Total Assets Growth & History (LH)
Labcorp Holdings's total assets was $18.39B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $18.39B | $13.7M | +0.07% |
| 2024 | 2024-12-31 | $18.38B | $1.65B | +9.89% |
| 2023 | 2023-12-31 | $16.73B | −$3.43B | −17.02% |
| 2022 | 2022-12-31 | $20.16B | −$230.3M | −1.13% |
| 2021 | 2021-12-31 | $20.39B | $313.7M | +1.56% |
| 2020 | 2020-12-31 | $20.07B | $2.03B | +11.22% |
| 2019 | 2019-12-31 | $18.05B | $1.86B | +11.50% |
| 2018 | 2018-12-31 | $16.19B | −$487.7M | −2.93% |
| 2017 | 2017-12-31 | $16.67B | $2.43B | +17.03% |
| 2016 | 2016-12-31 | $14.25B | $142.3M | +1.01% |
| 2015 | 2015-12-31 | $14.10B | $6.80B | +93.17% |
| 2014 | 2014-12-31 | $7.30B | $335.9M | +4.82% |
| 2013 | 2013-12-31 | $6.97B | $170.9M | +2.52% |
| 2012 | 2012-12-31 | $6.79B | $683.2M | +11.18% |
| 2011 | 2011-12-31 | $6.11B | −$76.0M | −1.23% |
| 2010 | 2010-12-31 | $6.19B | $1.35B | +27.91% |
| 2009 | 2009-12-31 | $4.84B | $168.3M | +3.60% |
| 2008 | 2008-12-31 | $4.67B | — | — |
Labcorp Holdings quarterly total assets
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18.53B | $472.4M | +2.62% |
| Q1 2026 | 2026-03-31 | $19.09B | $1.48B | +8.43% |
| Q4 2025 | 2025-12-31 | $18.39B | $13.7M | +0.07% |
| Q3 2025 | 2025-09-30 | $18.26B | −$350.9M | −1.89% |
| Q2 2025 | 2025-06-30 | $18.06B | $1.35B | +8.06% |
| Q1 2025 | 2025-03-31 | $17.60B | $1.07B | +6.49% |
| Q4 2024 | 2024-12-31 | $18.38B | $1.65B | +9.89% |
| Q3 2024 | 2024-09-30 | $18.61B | $1.73B | +10.22% |
| Q2 2024 | 2024-06-30 | $16.71B | −$1.01B | −5.68% |
| Q1 2024 | 2024-03-31 | $16.53B | −$3.67B | −18.16% |
| Q4 2023 | 2023-12-31 | $16.73B | −$3.43B | −17.02% |
| Q3 2023 | 2023-09-30 | $16.89B | −$2.94B | −14.83% |
| Q2 2023 | 2023-06-30 | $17.72B | −$2.68B | −13.16% |
| Q1 2023 | 2023-03-31 | $20.20B | −$528.4M | −2.55% |
| Q4 2022 | 2022-12-31 | $20.16B | −$230.3M | −1.13% |
| Q3 2022 | 2022-09-30 | $19.83B | −$1.04B | −4.99% |
| Q2 2022 | 2022-06-30 | $20.40B | −$14.0M | −0.07% |
| Q1 2022 | 2022-03-31 | $20.73B | $311.3M | +1.52% |
| Q4 2021 | 2021-12-31 | $20.39B | $313.7M | +1.56% |
| Q3 2021 | 2021-09-30 | $20.87B | $2.13B | +11.35% |
| Q2 2021 | 2021-06-30 | $20.42B | $2.57B | +14.39% |
| Q1 2021 | 2021-03-31 | $20.42B | $3.12B | +18.03% |
| Q4 2020 | 2020-12-31 | $20.07B | $2.03B | +11.22% |
| Q3 2020 | 2020-09-30 | $18.74B | $891.8M | +5.00% |
| Q2 2020 | 2020-06-30 | $17.85B | $104.7M | +0.59% |
| Q1 2020 | 2020-03-31 | $17.30B | $327.6M | +1.93% |
| Q4 2019 | 2019-12-31 | $18.05B | $1.86B | +11.50% |
| Q3 2019 | 2019-09-30 | $17.85B | $1.19B | +7.12% |
| Q2 2019 | 2019-06-30 | $17.74B | $1.24B | +7.51% |
| Q1 2019 | 2019-03-31 | $16.97B | $139.1M | +0.83% |
| Q4 2018 | 2018-12-31 | $16.19B | −$487.7M | −2.93% |
| Q3 2018 | 2018-09-30 | $16.66B | −$30.4M | −0.18% |
| Q2 2018 | 2018-06-30 | $16.50B | $1.60B | +10.75% |
| Q1 2018 | 2018-03-31 | $16.83B | $2.40B | +16.66% |
| Q4 2017 | 2017-12-31 | $16.67B | $2.43B | +17.03% |
| Q3 2017 | 2017-09-30 | $16.69B | $2.21B | +15.25% |
| Q2 2017 | 2017-06-30 | $14.90B | $703.5M | +4.95% |
| Q1 2017 | 2017-03-31 | $14.43B | $17.6M | +0.12% |
| Q4 2016 | 2016-12-31 | $14.25B | $142.3M | +1.01% |
| Q3 2016 | 2016-09-30 | $14.48B | $60.7M | +0.42% |
| Q2 2016 | 2016-06-30 | $14.20B | −$266.2M | −1.84% |
| Q1 2016 | 2016-03-31 | $14.41B | $259.8M | +1.84% |
| Q4 2015 | 2015-12-31 | $14.10B | $6.80B | +93.17% |
| Q3 2015 | 2015-09-30 | $14.42B | $7.19B | +99.43% |
| Q2 2015 | 2015-06-30 | $14.47B | $7.32B | +102.46% |
| Q1 2015 | 2015-03-31 | $14.15B | $7.16B | +102.37% |
| Q4 2014 | 2014-12-31 | $7.30B | $335.9M | +4.82% |
| Q3 2014 | 2014-09-30 | $7.23B | $545.1M | +8.15% |
| Q2 2014 | 2014-06-30 | $7.14B | $552.9M | +8.39% |
| Q1 2014 | 2014-03-31 | $6.99B | $423.0M | +6.44% |
| Q4 2013 | 2013-12-31 | $6.97B | $170.9M | +2.52% |
| Q3 2013 | 2013-09-30 | $6.69B | −$127.6M | −1.87% |
| Q2 2013 | 2013-06-30 | $6.59B | $493.6M | +8.09% |
| Q1 2013 | 2013-03-31 | $6.57B | $438.8M | +7.16% |
| Q4 2012 | 2012-12-31 | $6.79B | $683.2M | +11.18% |
| Q3 2012 | 2012-09-30 | $6.81B | $761.1M | +12.57% |
| Q2 2012 | 2012-06-30 | $6.10B | −$70.0M | −1.13% |
| Q1 2012 | 2012-03-31 | $6.13B | −$71.0M | −1.14% |
| Q4 2011 | 2011-12-31 | $6.11B | −$76.0M | −1.23% |
| Q3 2011 | 2011-09-30 | $6.05B | $1.01B | +19.92% |
| Q2 2011 | 2011-06-30 | $6.17B | $1.21B | +24.40% |
| Q1 2011 | 2011-03-31 | $6.20B | $1.27B | +25.69% |
| Q4 2010 | 2010-12-31 | $6.19B | $1.35B | +27.91% |
| Q3 2010 | 2010-09-30 | $5.05B | $217.5M | +4.50% |
| Q2 2010 | 2010-06-30 | $4.96B | $245.2M | +5.20% |
| Q1 2010 | 2010-03-31 | $4.93B | — | — |
| Q4 2009 | 2009-12-31 | $4.84B | $168.3M | +3.60% |
| Q3 2009 | 2009-09-30 | $4.83B | — | — |
| Q2 2009 | 2009-06-30 | $4.71B | — | — |
| Q4 2008 | 2008-12-31 | $4.67B | — | — |
Labcorp Holdings total assets trends
Over the last five fiscal years, Labcorp Holdings's total assets decreased from $20.07B to $18.39B, a change of −$1.68B. The latest reported quarter, Q2 2026, shows $18.53B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...